Indiana med spa & injectable regulations
What’s changing for med spas and injectors in Indiana — GLP-1 compounding, scope-of-practice, and enforcement — plus the federal FDA and Federal Register actions that apply in Indiana. Med Spa Radar monitors it all and tells you, in plain language, what changed and what to do.
Coming into force in Indiana
Already law, not yet binding — this is the deadline you can still prepare for.
- Jan 1, 2027in 138 days
IN SB0282: Compounding drugs; registration of medical spas.
What to do: Medical spas must register with the Indiana medical licensing board by January 1, 2027, and designate a responsible practitioner who ensures compliance with the compounding regulations laid out in section IC 16-42-22.5.
read the statute →
Opening a med spa in Indiana? Start with who may own one, the medical director rules, and who may inject in Indiana →
Latest Indiana changes
- CRITICALLegiScanMar 5, 2026
IN SB0282: Compounding drugs; registration of medical spas.
New regulations for medical spas in Indiana take effect in 2027.
Federal changes that apply in Indiana
FDA and Federal Register actions are nationwide — they govern Indiana practices too.
- CAUTIONFEDERALFederal RegisterJul 30, 2026
FDA / Federal Register Notice: Outsourcing Facility Fee Rates for Fiscal Year 2027
New FDA fees for outsourcing facilities will impact med spas using compounds.
- CRITICALFEDERALFDA Warning LetterJul 8, 2026
FDA Warning Letter: Spa De Soleil, Inc. (Drugs)
FDA warns Spa De Soleil over drug compounding practices.
- MONITORFEDERALFederal RegisterJun 26, 2026
FDA / Federal Register Notice: List of Bulk Drug Substances for Which There Is a Clinical Need Under Section 503B of the Federal Food, Drug, and Cosmetic Act; Extension of Comment Period
FDA extends comment period on GLP-1 compounding decisions.
- CRITICALFEDERALFDA Warning LetterJun 23, 2026
FDA Warning Letter: ketaminelab.org (Drugs)
FDA Warning Letter issued to ketaminelab.org for drugs.
- CRITICALFEDERALFTC EnforcementJun 12, 2026
FTC Files Contempt Motion Against Amare Global and Three Individuals Over Unsubstantiated Health Claims
FTC targets deceptive health claims affecting aesthetic practices.
- CAUTIONFEDERALFDA Drug ShortagesJun 11, 2026
FDA shortage: Liraglutide Injection (Injection) — Currently in Shortage
Liraglutide is still on the FDA shortage list for compounding.
What we monitor in Indiana
- Indiana legislature — bills on injectables, GLP-1s & scope of practice
- Indiana Board of Nursing — injector scope & delegation
- Indiana Medical Board — physician supervision & ownership rules
- Indiana Board of Pharmacy — compounding & 503A/503B
- U.S. FDA — enforcement, warning letters, recalls, shortages
- Federal Register — new rules on compounding & aesthetics
Indiana med-spa compliance rules
15 rules across 7topics — physician delegation, the good-faith exam, ownership & corporate practice of medicine, RN/NP scope, med-spa registration, advertising, and enforcement — each linked to its primary source. Reference and monitoring, not legal advice.
Physician supervision & delegation
Indiana defines the practice of medicine broadly; injectables and energy procedures are the practice of medicine unless performed by a licensed professional within scope or under proper delegation.
The “practice of medicine” includes prescribing or administering any form of treatment and procedures that cut, burn, or vaporize tissue by mechanical means, laser, or penetration of the skin — the statutory basis for treating cosmetic injectables and energy-device procedures as medicine.
Good-faith examination
Botox and fillers are legend (prescription) drugs, so a valid prescriber and a lawful prescribing relationship are required.
A prescriber may issue a prescription without a prior in-person exam only if the applicable standard of care is satisfied, the prescription is within the prescriber’s scope, and a valid provider-patient relationship has been established — including identity/location verification, informed consent, a medical history sufficient to establish a diagnosis, and discussion of the diagnosis and risks/benefits.
Ownership & corporate practice of medicine
Indiana is comparatively permissive and does not impose a strict corporate-practice-of-medicine ban.
An employment or other contractual relationship between an entity and a licensed physician is not the unlawful practice of medicine, as long as the entity does not direct or control the physician’s independent medical acts, decisions, or judgment. So a non-physician-owned entity may employ physicians without controlling their clinical judgment.
RN / NP scope for injectables
Registered nursing includes executing regimens delegated by a physician or other authorized prescriber. An RN does not independently prescribe; an RN administers injectables pursuant to a valid order within the delegated regimen.
An advanced practice registered nurse may obtain independent prescriptive authority only through the Board of Nursing’s program, renewed on two-year cycles.
A collaborating physician may delegate authority to a physician assistant to prescribe legend drugs and medical devices.
Med-spa registration & licensing
Indiana is one of the first states with a dedicated med-spa law — a registration regime taking effect over 2026–2027.
Indiana enacted a dedicated Medical Spas chapter (Senate Enrolled Act 282), effective July 1, 2026. A “medical spa” is a facility that offers medical health care services, prepares/administers/dispenses prescription drugs (including IV/IM/subcutaneous delivery), and holds itself out as focused on cosmetic/lifestyle treatments — expressly including botulinum toxin injections, dermal fillers, weight loss, hormone therapies, and non-surgical laser/energy-device use. A physician’s office and otherwise state-licensed facilities are excluded.
Beginning January 1, 2027, a medical spa must be registered to do business in Indiana; the board must establish the registration procedure by October 1, 2026, and the application must identify the responsible practitioner and their collaborating/supervising physician. The board may fine an unregistered operator up to $5,000.
Each med spa must have a responsible practitioner (a physician, a qualifying APRN, or a PA with delegated prescriptive authority) with relevant training, who must be physically present enough to ensure compliance and must ensure every worker is licensed and trained for the services they perform.
A medical spa must notify the board within 15 days of a patient’s serious adverse event (a death, a life-threatening event, or a hospitalization or its prolongation).
Advertising rules
An advertisement that names a practitioner must state the profession/license held and must not include deceptive or misleading information — anything misrepresenting a practitioner’s profession, skills, training, expertise, degree, board certification, or license. Violations subject the practitioner to board discipline.
Deceptive med-spa marketing to consumers is also unlawful under the Deceptive Consumer Sales Act, enforceable by the Attorney General.
Disciplinary landscape
Knowingly or intentionally practicing medicine without a license is a Level 5 felony.
The Attorney General, a prosecuting attorney, the board, or any citizen may bring an action in the name of the state to enjoin a person from practicing medicine without a license.
A practitioner is subject to board discipline for grounds including fraud or material deception in providing professional services and advertising services in a false or misleading manner.
Current as of Jul 26, 2026. Verify against the linked primary source and consult qualified counsel before acting — rules change and turn on your specific facts.
Indiana med spa compliance — FAQ
- Where do Indiana med spa and injectable regulations come from?
- Indiana med spas and injectors are governed by a mix of state and federal authorities — the Indiana legislature, and the state's boards of nursing, medicine, and pharmacy, alongside federal bodies like the FDA and the Federal Register. Med Spa Radar monitors all of them for Indiana and flags what changed in plain language.
- Does the FDA's GLP-1 compounding guidance apply in Indiana?
- Yes — federal FDA actions on GLP-1 compounding (semaglutide, tirzepatide) apply nationwide, including in Indiana. We track those federal changes alongside any Indiana-specific rules so you see the full picture for your practice.
- How do I keep up with Indiana regulatory changes?
- Med Spa Radar sends a free weekly Brief on what changed across Indiana, the FDA, and the Federal Register. Members get the exact "what to do" for their states in real time. It's regulatory monitoring, not legal advice.
Get Indiana changes as they publish
We scan the Indiana legislature and licensing boards daily, plus the FDA and the Federal Register. Free weekly Brief — what changed, in plain language, with the source.
Free · unsubscribe in one click · we never sell your address
← All states · Regulatory monitoring, not legal advice.